Projects per year
Personal profile
Area of Expertise
The main focus of my research is to discover and develop bioactive natural products from microorganisms as drugs or drug leads for the treatment of cancer, infectious diseases, or other human medical conditions. In addition, I recently initiated a collaborative project for the engineering of novel oncolytic virus for cancer chemoimmunotherapy.
Key words: anti-aging, anti-cancer, anti-infective, crowd-sourcing, crowd-funding, drug discovery, drug development, natural product, synthetic biology, chemoimmunotherapy, contract service
Key words: anti-aging, anti-cancer, anti-infective, crowd-sourcing, crowd-funding, drug discovery, drug development, natural product, synthetic biology, chemoimmunotherapy, contract service
Education/Academic qualification
PhD in Botany & Microbiology, Michigan State University
MS in Phytochemistry, Institute of Botany of the Chinese Academy of Sciences
BS in Microbiology, Huazhong Agricultural University
Fingerprint Dive into the research topics where Yiqiang (Eric) Cheng is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
Histone Deacetylase Inhibitors
Medicine & Life Sciences
Multigene Family
Medicine & Life Sciences
Polyketide Synthases
Medicine & Life Sciences
Burkholderia
Medicine & Life Sciences
Peptide Synthases
Medicine & Life Sciences
Biosynthesis
Chemical Compounds
Genes
Chemical Compounds
Streptomyces
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects 2013 2018
- 3 Finished
High-Resolution Tandem Mass Spectrometer for Advanced Biomolecular Research
Prokai, L., Forster, M. & Cheng, Y. (.
27/01/17 → 31/01/18
Project: Research
Discover and Engineer New Histone Deacetylase Inhibitors as Anticancer Agents
NCI: National Cancer Institute
1/06/13 → 31/05/15
Project: Research
Research Output 1998 2020
Overexpression of somatostatin receptor type 2 in neuroendocrine tumors for improved Ga68-DOTATATE imaging and treatment
Guenter, R., Aweda, T., Carmona Matos, D. M., Jang, S., Whitt, J., Cheng, Y. Q., Liu, X. M., Chen, H., Lapi, S. E. & Jaskula-Sztul, R., Jan 2020, In : Surgery (United States). 167, 1, p. 189-196 8 p.Research output: Contribution to journal › Article
Neuroendocrine Tumors
Histone Deacetylase Inhibitors
Neuroendocrine Cells
Therapeutics
Tumor Cell Line
Origin and bioactivities of thiosulfinated FK228
Liu, X., Currens, G. C., Xue, L. & Cheng, Y., 1 Jan 2019, In : MedChemComm. 10, 4, p. 538-542 5 p.Research output: Contribution to journal › Article
Bioactivity
Silica Gel
Burkholderia
Histone Deacetylases
romidepsin
Pulmonary carcinoid surface receptor modulation using histone deacetylase inhibitors
Guenter, R. E., Aweda, T., Matos, D. M. C., Whitt, J., Chang, A. W., Cheng, E. Y., Liu, X. M., Chen, H., Lapi, S. E. & Jaskula-Sztul, R., Jun 2019, In : Cancers. 11, 6, 767.Research output: Contribution to journal › Article
Open Access
Histone Deacetylase Inhibitors
Carcinoid Tumor
Lung
Somatostatin
Positron-Emission Tomography
The ADEP biosynthetic gene cluster in Streptomyces hawaiiensis NRRL 15010 reveals an accessory clpP gene as a novel antibiotic resistance factor
Thomy, D., Culp, E., Adamek, M., Cheng, E. Y., Ziemert, N., Wright, G. D., Sass, P. & Brötz-Oesterhelt, H., 1 Jan 2019, In : Applied and Environmental Microbiology. 85, 20, e01292-19.Research output: Contribution to journal › Article
antibiotic resistance
R Factors
Streptomyces
Multigene Family
Microbial Drug Resistance
6
Citations
(Scopus)
Chromobacterium spp. mediate their anti-Plasmodium activity through secretion of the histone deacetylase inhibitor romidepsin
Saraiva, R. G., Huitt-Roehl, C. R., Tripathi, A., Cheng, Y. Q., Bosch, J., Townsend, C. A. & Dimopoulos, G., 1 Dec 2018, In : Scientific Reports. 8, 1, 6176.Research output: Contribution to journal › Article
Chromobacterium
histone deacetylase
Plasmodium
secretion
antimalarials